Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors

Cell Calcium

Volumn 47, Issue 3, 2010, Pages 264-272

  Alberdi, Elena ^a   Sánchez Gómez, M Victoria ^a   Cavaliere, Fabio ^a   Pérez Samartín, Alberto ^a   Zugaza, José Luis ^b   Trullas, Ramón ^c   Domercq, María ^a   Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CIC BIOGUNE   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

Author keywords

Alzheimer disease; AMPA receptors; Amyloid oligomers; Mitochondrial damage; NMDA receptors

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLIGOMER; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENTORHINAL CORTEX; HIPPOCAMPUS; LONG TERM EXPOSURE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 77949267093     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.12.010     Document Type: Article

References (44)

1. Billings L.M., Oddo S., Green K.N., McGaugh J.L., and LaFerla F.M. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45 (2005) 675-688
2. Oddo S., Caccamo A., Tran L., Lambert M.P., Glabe C.G., Klein W.L., and LaFerla F.M. Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease: a link between Aβ and tau pathology. J. Biol. Chem. 281 (2006) 1599-1604
3. Kuo Y.M., Emmerling M.R., Vigo-Pelfrey C., Kasunic T.C., Kirkpatrick J.B., Murdoch G.H., Ball M.J., and Roher A.E. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271 (1996) 4077-4081
4. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
5. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., and Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10417-10422
6. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid β oligomers. J. Neurosci. 24 (2004) 10191-10200
7. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., and Rogers J. Soluble amyloid b peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155 (1999) 853-862
8. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., and Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46 (1999) 860-866
9. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Buxbaum J.D. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283 (2000) 1571-1577
10. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
11. Wang H.Y., Lee D.H.S., D'Andrea M.R., Peterson P.A., Shank R.P., and Reitz A.B. β-Amyloid (1-42) binds to alpha 7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275 (2000) 5626-5632
12. Arispe N., Diaz J.C., and Simakova O. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers. Biochim. Biophys. Acta-Biomembr. 1768 (2007) 1952-1965
13. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., and Klein W.L. Aβ oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282 (2007) 11590-11601
14. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
15. Kelly B.L., and Ferreira A. β Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-aspartate receptors in hippocampal neurons. J. Biol. Chem. 281 (2006) 28079-28089
16. Deshpande A., Kawai H., Metherate R., Glabe C.G., and Busciglio J. A role for synaptic zinc in activity-dependent Aβ oligomer formation and accumulation at excitatory synapses. J. Neurosci. 29 (2009) 4004-4015
17. +-evoked glutamate release from adult rat hippocampal slices. Neurobiol. Aging (2008) 10.1016/j.neurobiolaging.2008.08.009
18. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., and Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62 (2009) 788-801
19. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
20. Klein W.L. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41 (2002) 345-352
21. Gottlieb M., Leal-Campanario R., Campos-Esparza M.R., Sánchez-Gómez M.V., Alberdi E., Arranz A., Delgado-García J.M., Gruart A., and Matute C. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiol. Dis. 23 (2006) 374-386
22. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
23. Hajnóczky G., Robb-Gaspers L.D., Seitz M.B., and Thomas A.P. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82 (1995) 415-424
24. Pozzo-Miller L.D., Mahanty N.K., Connor J.A., and Landis D.M. Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists. Neuroscience 63 (1994) 471-487
25. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., and Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signalling pathway. J. Neurosci. 27 (2007) 2866-2875
26. Parameshwaran K., Sims C., Kanju P., Vaithianathan T., Shonesy B.C., Dhanasekaran M., Bahr B.A., and Suppiramaniam V. Amyloid beta-peptide Aβ(1-42) but not Aβ(1-40) attenuates synaptic AMPA receptor function. Synapse 61 (2007) 367-374
27. 2+ overload underlies Aβ oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS ONE 3 (2008) e2718
28. De Lacoste M.C., and White C.L. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol. Aging 14 (1993) 1-16
29. Kluge A., Hailer N.P., Horvath T.L., Bechmann I., and Nitsch R. Tracing of the entorhinal-hippocampal pathway in vitro. Hippocampus 8 (1998) 57-68
30. Szegedi V., Juhasz G., Budai D., and Penke B. Divergent effects of Aβ 1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res. 1062 (2005) 120-126
31. Blanchard B.J., Chen A., Rozeboom L.M., Stafford K.A., Weigele P., and Ingram V.M. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14326-14332
32. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S., and Nishizaki T. The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors. Biochem. Biophys. Res. Commun. 294 (2002) 42-45
33. Atlante A., Calissano P., Bobba A., Giannattasio S., Marra E., and Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497 (2001) 1-5
34. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 80 (2000) 315-360
35. Butterfield D.A., and Pocernich C.B. The glutamatergic system and Alzheimer's disease: therapeutic implications. CNS Drugs 17 (2003) 641-652
36. Cacabelos R., Takeda M., and Winblad B. The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease. Int. J. Geriatr. Psych. 14 (1999) 3-47
37. Francis P.T. Glutamatergic systems in Alzheimer's disease. Int. J. Geriatr. Psych. 18 (2003) S15-S21
38. Mattson M.P., and Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34 (2003) 385-397
39. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-595
40. Verkhratsky A., and Kirchhoff F. NMDA Receptors in glia. Neuroscientist 13 (2007) 28-37
41. Matute C., Alberdi E., Domercq M., et al. Excitotoxic damage to white matter. J. Anat. 210 (2007) 693-702
42. Bakiri Y., Burzomato V., Frugier G., Hamilton N.B., Káradóttir R., and Attwell D. Glutamatergic signaling in the brain's white matter. Neuroscience 158 (2009) 266-274
43. Rodríguez J.J., Olabarria M., Chvatal A., and Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16 (2009) 378-385
44. Heneka M.T., Rodríguez J.J., and Verkhratsky A. Neuroglia in neurodegeneration. Brain Res. Rev. (2009) 10.1016/j.brainresrev.2009.11.004 (Epub ahead of print)